Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment
Clinical trial NCT04423367 · COMPLETED
Trial details
- NCT number
- NCT04423367
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-13
- Primary completion
- 2024-07-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.